Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea
Public ClinicalTrials.gov record NCT03667222. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PRISM: A Double Blind, Randomized, Vehicle Controlled Phase 2 Study to Assess the Safety and Efficacy of BPX-04 Minocycline Topical Gel in the Treatment of Inflammatory Lesions of Papulopustular Rosacea
Study identification
- NCT ID
- NCT03667222
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- BioPharmX, Inc.
- Industry
- Enrollment
- 207 participants
Conditions and interventions
Conditions
Interventions
- minocycline topical gel Drug
- topical gel vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 17, 2018
- Primary completion
- May 16, 2019
- Completion
- Aug 16, 2019
- Last update posted
- Jul 9, 2019
2018 – 2019
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Center | Anaheim Hills | California | 92807 | — |
| Study Center | Miami | Florida | 33175 | — |
| Study Center | Miramar | Florida | 33027 | — |
| Study Center | Baton Rouge | Louisiana | 70809 | — |
| Study Center | New Orleans | Louisiana | 70115 | — |
| Study Center | Needham | Massachusetts | 02135 | — |
| Study Center | Saint Joseph | Missouri | 64506 | — |
| Study Center | Morristown | New Jersey | 07960 | — |
| Study Center | High Point | North Carolina | 27262 | — |
| Study Center | Philadelphia | Pennsylvania | 19103 | — |
| Study Center | Austin | Texas | 78759 | — |
| Study Center | San Antonio | Texas | 78213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03667222, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 9, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03667222 live on ClinicalTrials.gov.